Gestational diabetes mellitus in relation to maternal dietary heme iron and nonheme iron intake

Chunfang Qiu, Cuilin Zhang, Bizu Gelaye, Daniel A Enquobahrie, Ihunnaya O Frederick, Michelle A Williams, Chunfang Qiu, Cuilin Zhang, Bizu Gelaye, Daniel A Enquobahrie, Ihunnaya O Frederick, Michelle A Williams

Abstract

Objective: Higher heme iron intake is associated with increased type 2 diabetes risk. However, no previous study has evaluated gestational diabetes mellitus (GDM) risk in relation to heme iron intake during pregnancy. We investigated associations of maternal preconceptional and early pregnancy heme and nonheme iron intake with subsequent GDM risk.

Research design and methods: We conducted a prospective cohort study of 3,158 pregnant women. A food frequency questionnaire was used to assess maternal diet. Multivariable generalized linear regression models were used to derive estimates of relative risks (RRs) and 95% CIs.

Results: Approximately 5.0% of the cohort developed GDM (n=158). Heme iron intake was positively and significantly associated with GDM risk (Ptrend=0.04). After adjusting for confounders, women reporting the highest heme iron intake levels (≥1.52 vs. <0.48 mg per day) experienced a 3.31-fold-increased GDM risk (95% CI 1.02-10.72). In fully adjusted models, we noted that a 1-mg per day increase in heme iron was associated with a 51% increased GDM risk (RR 1.51 [95% CI 0.99-2.36]). Nonheme iron was inversely, though not statistically significantly, associated with GDM risk, and the corresponding RRs were 1.00, 0.83, 0.62, and 0.61 across quartiles of nonheme iron intake (Ptrend=0.08).

Conclusions: High levels of dietary heme iron intake during the preconceptional and early pregnancy period may be associated with increased GDM risk. Associations of GDM risk with dietary nonheme iron intake are less clear. Confirmation of these findings by future studies is warranted.

Figures

Figure 1
Figure 1
Relationship between maternal dietary heme iron intake in early pregnancy and risk of GDM (solid line) with 95% CIs (dotted lines) after adjusting for daily energy intake; maternal age; race/ethnicity; parity; physical activity; prepregnancy BMI; and dietary fiber, vitamin C, saturated fat, cholesterol, and red and processed meat intake. The vertical bars along the dietary heme iron intake axis indicate the distribution of study subjects.

References

    1. Yip R, Dallman PR. Iron. In Present Knowledge in Nutrition .7th ed. Ziegler EE, Filer LJ, Eds. Washington, DC, ILSI Press, 1996, p. 277–292
    1. Galan P, Vergnaud AC, Tzoulaki I, et al. Low total and nonheme iron intakes are associated with a greater risk of hypertension. J Nutr 2010;140:75–80
    1. Rajpathak SN, Crandall JP, Wylie-Rosett J, Kabat GC, Rohan TE, Hu FB. The role of iron in type 2 diabetes in humans. Biochim Biophys Acta 2009;1790:671–681
    1. Cade JE, Moreton JA, O’Hara B, et al. Diet and genetic factors associated with iron status in middle-aged women. Am J Clin Nutr 2005;82:813–820
    1. Klipstein-Grobusch K, Koster JF, Grobbee DE, et al. Serum ferritin and risk of myocardial infarction in the elderly: the Rotterdam Study. Am J Clin Nutr 1999;69:1231–1236
    1. Jiang R, Manson JE, Meigs JB, Ma J, Rifai N, Hu FB. Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA 2004;291:711–717
    1. Lee DH, Folsom AR, Jacobs DR., Jr Dietary iron intake and type 2 diabetes incidence in postmenopausal women: the Iowa Women’s Health Study. Diabetologia 2004;47:185–194
    1. Rajpathak S, Ma J, Manson J, Willett WC, Hu FB. Iron intake and the risk of type 2 diabetes in women: a prospective cohort study. Diabetes Care 2006;29:1370–1376
    1. Hallberg L, Hultén L, Gramatkovski E. Iron absorption from the whole diet in men: how effective is the regulation of iron absorption? Am J Clin Nutr 1997;66:347–356
    1. Skikne B, Baynes RD. Iron absorption. In Iron Metabolism in Health and Disease. Brock JH, Halliday JW, Pippard MJ, Powell LW, Eds. London, WB Saunders, 1994, p. 151–187
    1. Jehn ML, Guallar E, Clark JM, et al. A prospective study of plasma ferritin level and incident diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 2007;165:1047–1054
    1. Lao TT, Chan LY, Tam KF, Ho LF. Maternal hemoglobin and risk of gestational diabetes mellitus in Chinese women. Obstet Gynecol 2002;99:807–812
    1. Chen X, Scholl TO, Stein TP. Association of elevated serum ferritin levels and the risk of gestational diabetes mellitus in pregnant women: the Camden Study. Diabetes Care 2006;29:1077–1082
    1. Bo S, Menato G, Villois P, et al. Iron supplementation and gestational diabetes in midpregnancy. Am J Obstet Gynecol 2009;201:158.e1–158.e6
    1. Chan KK, Chan BC, Lam KF, Tam S, Lao TT. Iron supplement in pregnancy and development of gestational diabetes: a randomised placebo-controlled trial. BJOG 2009;116:789–797
    1. Enquobahrie DA, Williams MA, Qiu C, Luthy DA. Early pregnancy lipid concentrations and the risk of gestational diabetes mellitus. Diabetes Res Clin Pract 2005;70:134–142
    1. Patterson RE, Kristal AR, Tinker LF, Carter RA, Bolton MP, Agurs-Collins T. Measurement characteristics of the Women’s Health Initiative food frequency questionnaire. Ann Epidemiol 1999;9:178–187
    1. Office of Dietary Supplements, National Institutes of Health. Dietary supplement fact sheet: iron [article online], 2007. Available from Accessed 27 February 2011
    1. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2003;26(Suppl. 1):S5–S20
    1. Hastie TJ, Tibshirani RJ. Generalized Additive Models. London, Chapman-Hall, 1990
    1. Kang JO. Chronic iron overload and toxicity: clinical chemistry perspective. Clin Lab Sci 2001;14:209–219
    1. Reif DW. Ferritin as a source of iron for oxidative damage. Free Radic Biol Med 1992;12:417–427
    1. Wilson JG, Lindquist JH, Grambow SC, Crook ED, Maher JF. Potential role of increased iron stores in diabetes. Am J Med Sci 2003;325:332–339
    1. Green A, Basile R, Rumberger JM. Transferrin and iron induce insulin resistance of glucose transport in adipocytes. Metabolism 2006;55:1042–1045
    1. Fernández-Real JM, López-Bermejo A, Ricart W. Cross-talk between iron metabolism and diabetes. Diabetes 2002;51:2348–2354

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe